Moneycontrol PRO
HomeNewsCadila health

Cadila Health

Jump to
  • Cadila Health Consolidated December 2021 Net Sales at Rs 3,655.00 crore, down 3.7% Y-o-Y

  • Cadila Health Standalone December 2021 Net Sales at Rs 1,830.30 crore, down 4.61% Y-o-Y

  • Cadila Health Standalone September 2021 Net Sales at Rs 2,008.90 crore, down 2.33% Y-o-Y

  • Cadila Health Consolidated June 2021 Net Sales at Rs 4,025.40 crore, up 10.59% Y-o-Y

  • Cadila Health Standalone June 2021 Net Sales at Rs 2,123.40 crore, up 18.24% Y-o-Y

  • Cadila Health Consolidated March 2021 Net Sales at Rs 3,846.70 crore, up 2.52% Y-o-Y

  • Cadila Health Standalone March 2021 Net Sales at Rs 2,018.80 crore, up 11.4% Y-o-Y

  • COVID-19 Vaccine | Cadila Health says it is ‘on track’ for May submission of vaccine to DCGI

    Cadila will file for emergency use authorisation after it has submitted its vaccine to the Drugs Controller General of India

  • Cadila Health Consolidated December 2020 Net Sales at Rs 3,795.60 crore, up 4.33% Y-o-Y

  • Cadila Health Consolidated December 2020 Net Sales at Rs 3,795.60 crore, up 4.33% Y-o-Y

  • Cadila Health Standalone December 2020 Net Sales at Rs 1,918.80 crore, up 12.14% Y-o-Y

  • Cadila Health Standalone September 2020 Net Sales at Rs 2,056.90 crore, up 22.24% Y-o-Y

  • Cadila Health Consolidated September 2020 Net Sales at Rs 3,820.00 crore, up 13.47% Y-o-Y

  • Cadila Health Consolidated June 2020 Net Sales at Rs 3,639.90 crore, up 4.11% Y-o-Y

  • Cadila Health Standalone June 2020 Net Sales at Rs 1,795.90 crore, up 33.64% Y-o-Y

  • Cadila Health Standalone March 2020 Net Sales at Rs 1,812.20 crore, up 15.43% Y-o-Y

  • Cadila Health Consolidated March 2020 Net Sales at Rs 3,752.10 crore, up 0.52% Y-o-Y

  • Cadila Health Consolidated December 2019 Net Sales at Rs 3,638.10 crore, up 1.68% Y-o-Y

  • Cadila Health Standalone December 2019 Net Sales at Rs 1,848.60 crore, up 10.33% Y-o-Y

  • Cadila Health Standalone December 2019 Net Sales at Rs 1,848.60 crore, up 10.33% Y-o-Y

  • Infosys, Cadila Health among 5 stocks where brokerages raise target; here's why

    According to Nomura, the overhang of whistleblower allegations is now behind and will prefer Infosys to TCS on valuations basis

  • Buy Cadila Health; target of Rs 275: Motilal Oswal

    Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 275 in its research report dated August 10, 2019.

  • Cadila Health Consolidated June 2019 Net Sales at Rs 3,496.30 crore, up 20.82% Y-o-Y

  • Cadila Health Standalone June 2019 Net Sales at Rs 1,343.80 crore, down 10.71% Y-o-Y

  • Buy Cadila Health; target of Rs 345: Motilal Oswal

    Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 345 in its research report dated May 29, 2019.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347